Analysis of drug targets of immune function-related drugs predicted the future of immune-targeted drugs in sepsis, and the results showed that nine target loci (CSF2RA/B, CSF3R, IFNGR1/2, IL7R, PDL1, CTLA4, and LAG3) were higher in sepsis than in healthy populations, as well as differences in high-/low-risk groups (Figures 8E, F). The gene discussed is IFNGR1; the disease is Sepsis.